Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nasopharyngeal Cancer”

1,154 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,154 results

Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Not applicableUnknownNCT03942380
What this trial is testing

Cell-free Tumor DNA in Head and Neck Cancer Patients

Who this might be right for
Head and Neck CancerHead and Neck NeoplasmsHead and Neck Squamous Cell Carcinoma+24 more
Christian von Buchwald 500
Not applicableStudy completedNCT05292027
What this trial is testing

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sichuan Cancer Hospital and Research Institute 84
Not applicableActive Not RecruitingNCT06762470
What this trial is testing

Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma

Who this might be right for
Histopathological Diagnosis of Nasopharyngeal CarcinomaPatients with Nasopharyngeal Carcinoma Without Distant Metastases After AJCC/UACC 8th Edition
Jiangxi Provincial Cancer Hospital 325
Testing effectiveness (Phase 2)Looking for participantsNCT06029270
What this trial is testing

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Metastatic Nasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaStage IV Nasopharyngeal Carcinoma AJCC v8
National Cancer Institute (NCI) 156
Large-scale testing (Phase 3)Study completedNCT02143388
What this trial is testing

Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial

Who this might be right for
Local Advanced High Risk Nasopharyngeal Carcinoma
Zhao Chong 180
Not applicableUnknownNCT03025854
What this trial is testing

Prospective Study for Prognostic Biomarkers of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 600
Large-scale testing (Phase 3)UnknownNCT03908372
What this trial is testing

Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma

Who this might be right for
Stage II, IIINasopharyngeal Squamous Cell CarcinomaInduction Chemotheray+2 more
Chinese Academy of Medical Sciences 120
Testing effectiveness (Phase 2)UnknownNCT00363831
What this trial is testing

Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
The University of Hong Kong 42
Testing effectiveness (Phase 2)UnknownNCT04921995
What this trial is testing

Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal CarcinomaUnresectable Nasopharyngeal CarcinomaChemotherapy Effect+2 more
Fudan University 40
Not applicableStudy completedNCT03989297
What this trial is testing

PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Kiang Wu Hospital 104
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06688175
What this trial is testing

IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal NeoplasmsElderlyChemotherapy
The First Affiliated Hospital of Xiamen University 32
Testing effectiveness (Phase 2)Study completedNCT00004865
What this trial is testing

Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy

Who this might be right for
Head and Neck Cancer
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Looking for participantsNCT06323239
What this trial is testing

SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 148
Testing effectiveness (Phase 2)Looking for participantsNCT03556228
What this trial is testing

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Who this might be right for
Head and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more
VM Oncology, LLC 242
Not applicableUnknownNCT04810936
What this trial is testing

Early Nutritional Intervention in NPC Patients Undergoing Concurrent Chemoradiotherapy

Who this might be right for
MalnutritionNasopharyngeal Carcinoma
Guangdong Provincial People's Hospital 272
Testing effectiveness (Phase 2)Active Not RecruitingNCT03047265
What this trial is testing

Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 164
Testing effectiveness (Phase 2)Study completedNCT02605967
What this trial is testing

Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Novartis Pharmaceuticals 122
Not applicableStudy completedNCT03448341
What this trial is testing

Dysphagia Assessment After Swallowing Sparing RadioTherapy

Who this might be right for
Cancer of OropharynxCancer of Nasopharynx
Azienda Ospedaliero, Universitaria Pisana 74
Next Page